Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Trimetazidine Therapy in STEMI Patients Undergoing Primary PCI
NCT02826616Phase 4Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Jul 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trimetazidine in ST elevation myocardial infarction (STEMI), sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
trimetazidine
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02826616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02826616.